United States · FDA National Drug Code directory

SHISEIDO FUTURE Solution LX INFINITE TREATMENT PRIMER

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 58411-657_47b9be75-c9c2-b19a-e063-6294a90a3412
Product NDC: 58411-657
Form: EMULSION
Composition / generic term: TITANIUM DIOXIDE, OCTINOXATE, and ENSULIZOLE
Labeler: SHISEIDO AMERICAS CORPORATION
Marketing category: OTC MONOGRAPH DRUG
Marketing start / end (source format): 20210501
Source listing expiry: 20271231

Source-listed ingredients

TITANIUM DIOXIDE — 1.77 g/40mL
OCTINOXATE — 1.71 g/40mL
ENSULIZOLE — .428 g/40mL

These values do not establish equivalence or a dose recommendation.

Packages

1 TUBE in 1 CARTON (58411-657-10) / 40 mL in 1 TUBE · 58411-657-10

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →